Consensus for the most suitable trial design to assess therapy for rare vascular malformations: a Delphi study.

The observed agreement of 61.5% did not reach statistical significance, as the one-sided 95% confidence interval included the 60% threshold (0.44–1.00).

also in 111,027 other papers